With François Roubille, University Hospital Arnaud de Villeneuve, Montpellier - France and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
 
In this podcast, François Roubille joins Ruxandra Christodorescu  to discuss inflammation and coronary artery disease.
 
REFERENCES:
 
1.    Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377:1119-31. https://www.nejm.org/doi/10.1056/NEJMoa1707914
 
2.    Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019 Dec 26;381(26):2497-2505.
 
3.    Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med.;383:1838-1847.
 
4.    Tardif JC, Kouz S. Efficacy and safety of colchicine and spironolactone after myocardial infarction: the CLEAR-SYNERGY trial in perspective. Eur Heart J Acute Cardiovasc Care. 2024;13:843-4. https://academic.oup.com/ehjacc/article/13/12/843/7906243
 
5.    Byrne RA, Rossello X, Coughlan JJ, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720-826. https://academic.oup.com/eurheartj/article/44/38/3720/7243210
 
6.    Vrints C, Andreotti F, Koskinas KC, et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415-3537. https://academic.oup.com/eurheartj/article/45/36/3415/7743115

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör European Society of Cardiology. Innehållet i podden är skapat av European Society of Cardiology och inte av, eller tillsammans med, Poddtoppen.